Search Articles — Sudonull

https://sudonull.com/ai-vulnerabilities-fake-disease-fooled-chatgpt

Researcher created a fictional disease that AI took for reality. Learn about disinformation risks in language models and how to protect against false medical advice.

https://sudonull.com/breakthrough-in-parkinson-s-disease-treatment-jotrol-us-trials

Critical Analysis of Jupiter Neurosciences' Phase 2a JOTROL: Bioavailability, Finances, Supplements, and Hidden Risks. Read Before Believing the Breakthrough.

https://sudonull.com/crispr-pencil-gene-therapy-n-1-saved-an-infant

Doctors edited a newborn's liver by assembling therapy for a unique mutation. Learn how CRISPR-pencil is changing regulation and the future of medicine.

https://ymaho.com/sedentary-work-a-risk-factor-for-gynecological-diseases-dr-sonina

Gynecologist Tatyana Sonina: sedentary work provokes blood stagnation, fibroids, endometriosis, and pelvic varicose veins. Learn about risks and prevention.

https://ymaho.com/dream-genetic-switch-link-between-lifespan-and-diseases

Low DREAM activity increases lifespan in 92 species and protects against Alzheimer's disease. Learn about the genetic switch of aging and its impact on the risk of age-related diseases. Read details.

https://ymaho.com/universal-car-t-therapy-fda-allows-trials-for-autoimmune-diseases

FDA approved clinical trials of allogeneic CAR-T cell therapy QT-019C for lupus and scleroderma. Savings up to $100 billion, no chemotherapy. Learn about the breakthrough.

https://ymaho.com/ai-blood-test-for-dementia-diagnosis-of-neurodegenerative-diseases

New AI blood test distinguishes 4 types of dementia with 92.3% accuracy. Learn how GPND-AI is changing the diagnosis of Alzheimer's, Parkinson's, and mixed pathologies. Read more.

https://ymaho.com/imp761-first-lag-3-agonist-passes-phase-i-in-autoimmune-diseases

Analysis of IMP761 data from Immutep at EULAR 2026: a new class of drugs for treating rheumatoid arthritis without total immunosuppression. Safety, mechanism, and prospects. Read more.

https://ymaho.com/lag-3-agonist-imp761-first-clinical-success-in-autoimmune-diseases

LAG-3 agonist IMP761 has shown clinical efficacy in suppressing T-cells for the first time. Learn about the revolution in treating autoimmune diseases without side effects. Read more.

https://ymaho.com/diagnosis-of-dementia-how-ai-analyzes-blood-with-90-accuracy

GPND-AI blood test distinguishes 5 neurodegenerative diseases with 92.3% accuracy. Learn how AI will change diagnostics and the biomarker market in neurology. Read more.

https://ymaho.com/epidemiological-transition-mortality-from-ncds-three-times-higher

WHO recorded: 78% of deaths are caused by noncommunicable diseases. Find out why this is a death sentence for the healthcare system and what will happen next. Detailed analysis.

https://ymaho.com/gene-therapy-without-registration-russia-legalizes-bespoke-drugs

Russia will allow individual gene therapy for orphan diseases without state registration. A chance for children with deadly mutations. Learn how it works.

https://ymaho.com/ai-bot-helps-seniors-set-goals-before-doctor-visit

UTHealth Houston creates MyHealthPriorities AI for $1.3 million. The chatbot interviews patients with chronic diseases and generates a note for the doctor. Learn how the technology gives seniors a voice in their treatment.